Advertisement
Research Article| Volume 86, ISSUE 1, P45-48, January 1992

Changes in spirometry during consecutive admissions for infective pulmonary exacerbations in adolescent and adultcystic fibrosis

      This paper is only available as a PDF. To read, Please Download here.
      Changes in spirometry during consecutive admissions for treatment of pulmonary infective exacerbations were studied in 45 patients (24 males, 21 females) with cystic fibrosis (CF) who had required five or more such admissions. Over the overall study period there was a mean (sd) decline in FEV, of −112.1 (188.0) ml yr−1 (P < 0001) and in FVC of − 47.9 (82.4) ml yr−1 (P < 0001). FEV1 and FVC increased during each admission with treatment; however, the magnitude of this change became less over consecutive admissions by a mean value of −33.3 ml (45.0) (P<0.001) for FEV1, and −260 (72.2) ml (P<005) for FVC. In the majority of patients that died or underwent transplantation, FEV, at the time of the last admission did not rise above 800 ml despite full treatment.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Respiratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hodson ME
        Diseases of the respiratory system: bronchiectasis and cystic fibrosis.
        BrMed J. 1978; 1: 971-973
        • Levison H
        • Tabachnik E
        Pulmonary physiology.
        in: Hodson ME Norman AP Batten JC Cystic Fibrosis. Bailliere Tindall, London1983: 52-81
        • Redding GJ
        • Restuccia R
        • Cotton EK
        • Brooks JG
        Serial changes in pulmonary function in children hospitalised with cystic fibrosis.
        AmRev Respir Dis. 1982; 126: 31-36
        • Penketh ARL
        • Wise A
        • Mearns MB
        • Hodson ME
        • Batten JC
        Cystic fibrosis in adolescents and adults.
        Thorax. 1987; 42: 526-532
        • Mathews JNS
        • Altman DG
        • Campbell MJ
        • Royston P
        Analysis of serial measurements in medical research.
        BrMed J. 1990; 30: 230-235
        • Corey M
        • Levison H
        • Crozier D
        Five-to-seven year course of pulmonary function in cystic fibrosis.
        AmRev Respir Dis. 1976; 114: 1085-1092
        • Tomashefski JF
        • Vawter GF
        • Reid L
        Pulmonary pathology.
        in: Hodson ME Norman AP Batten JC Cystic Fibrosis. Bailliere Tindall, London1983: 31-51
        • Hoiby N
        • Doring G
        • Schiotz PO
        The role of immune complexes in the pathogenesis of bacterial infections.
        Ann Rev Microbiol. 1986; 40: 29-53
        • DasGupta MK
        • Zuberbuhler P
        • Abbi A
        • et al.
        Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunological profile in relation to pulmonary function in cystic fibrosis.
        J Clin Immunol. 1987; 7: 51-58
        • Wheeler WB
        • Williams M
        • Mathews WJ
        • Colten HR
        Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study.
        J Paediatr. 1984; 104: 695-699
        • Hodson ME
        • Beldon I
        • Batten JC
        Circulating immune complexes in patients with cystic fibrosis in relation to clinical features.
        Clin Allergy. 1985; 15: 363-369
        • Moss RB
        • Hsu YP
        • Lewiston NJ
        • et al.
        Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysac-charide and endotoxin A with mortality in cystic fibrosis.
        AmRev Respir Dis. 1986; 133: 648-652